Skip to content
中文产业新闻评分64Chinese source

恒瑞医药1类新药立康可泮（CFB抑制剂）获批上市

恒瑞医药1类新药CFB抑制剂获批上市

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.